Abstract

Chronic hepatitis B virus (HBV) infection is characterized by the presence of functionally exhausted HBV-specific CD8+ T cells. To characterize the possible residual effector ability of these cells, we reexposed CD8+ T cells from chronically HBV replicating mice to HBV antigens in an acute activation immune environment. We found that after transfer into naive mice, exhausted CD8+ T cells reexpanded in a comparable magnitude as naive CD8+ T cells in response to acute HBV infection; however, their proliferation intensity was significantly lower than that of CD8+ T cells from acute-resolving HBV replicating mice (AR mice). The differentiation phenotypes driven by acute HBV replication of donor exhausted and naive CD8+ T cells were similar, but were different from those of their counterparts from AR mice. Nevertheless, exhausted CD8+ T cells maintained less activated phenotype, an absence of effector cytokine production and poor antiviral function after HBV reexposure in an acute activation immune environment. We thus conclude that exhausted CD8+ T cells undergo a stable form of dysfunctional differentiation during chronic HBV replication and switching immune environment alone is not sufficient for the antiviral functional reconstitution of these cells.

Highlights

  • Hepatitis B virus (HBV) infection continues to be a major cause of chronic liver diseases worldwide [1]

  • The plasmid backbone has been shown to play an important role in determining hepatitis B virus (HBV) persistence in pAAV/HBV1.2 hydrodynamic injection (HI) mice, as the replacement of pAAV vector by another vector resulted in only transient HBV antigenemia

  • We analyzed the phenotypes of splenic CD8+ T cells in acute-resolving HBV-replicating (AR) and chronically HBVreplicating (CH) mice at 21 dpi

Read more

Summary

Introduction

Hepatitis B virus (HBV) infection continues to be a major cause of chronic liver diseases worldwide [1]. The outcomes of HBV infection vary greatly from person to person. Some subjects control infection efficiently and clear the virus either with or without a clinically evident liver inflammation [2]. Other patients fail to clear the virus and develop chronic infection, which often lead to the development of cirrhosis and hepatocellular carcinoma [3, 4].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.